Harry LeVine - Publications

Affiliations: 
University of Kentucky, Lexington, KY 
Area:
Biochemistry

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zhang J, Sandberg A, Konsmo A, Wu X, Nyström S, Nilsson KP, Konradsson P, LeVine H, Lindgren M, Hammarström P. Detection and imaging of Aβ1-42 and Tau fibrils by redesigned fluorescent X-34 analogues. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 29543355 DOI: 10.1002/Chem.201800501  0.4
2018 Fändrich M, Nyström S, Nilsson KPR, Böckmann A, LeVine H, Hammarström P. Amyloid fibril polymorphism - a challenge for molecular imaging and therapy. Journal of Internal Medicine. PMID 29360284 DOI: 10.1111/Joim.12732  0.33
2017 LeVine H, Spielmann HP, Matveev S, Cauvi FM, Murphy MP, Beckett TL, McCarty K, Lott IT, Doran E, Schmitt F, Head E. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan. Neurobiology of Aging. PMID 28385551 DOI: 10.1016/J.Jalz.2017.06.474  0.358
2016 Horton W, Sood A, Peerannawar S, Kugyela N, Kulkarni A, Tulsan R, Tran CD, Soule J, LeVine H, Török B, Török M. Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents. Bioorganic & Medicinal Chemistry Letters. PMID 27923619 DOI: 10.1016/J.Bmcl.2016.11.067  0.353
2016 Nilsson P, Bäck M, Appelqvist H, LeVine H. Anionic oligothiophenes compete for binding of X-34 but not PIB to recombinant Aβ amyloid fibrils and Alzheimer's disease brain-derived Aβ. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27767229 DOI: 10.1002/Chem.201604583  0.421
2016 Rosen RF, Tomidokoro Y, Farberg AS, Dooyema J, Ciliax B, Preuss TM, Neubert TA, Ghiso JA, LeVine H, Walker LC. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease. Neurobiology of Aging. 44: 185-96. PMID 27318146 DOI: 10.1016/J.Neurobiolaging.2016.04.019  0.42
2016 LeVine H, Walker LC. What amyloid ligands can tell us about molecular polymorphism and disease. Neurobiology of Aging. 42: 205-12. PMID 27143437 DOI: 10.1016/J.Neurobiolaging.2016.03.019  0.322
2016 Hartz AM, Zhong Y, Wolf A, LeVine H, Miller DS, Bauer B. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1930-41. PMID 26865616 DOI: 10.1523/Jneurosci.0350-15.2016  0.358
2016 Meier S, Bell M, Lyons DN, Rodriguez-Rivera J, Ingram A, Fontaine SN, Mechas E, Chen J, Wolozin B, LeVine H, Zhu H, Abisambra JF. Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1001-7. PMID 26791227 DOI: 10.1523/Jneurosci.3029-15.2016  0.372
2015 Qosa H, Mohamed LA, Batarseh YS, Alqahtani S, Ibrahim B, LeVine H, Keller JN, Kaddoumi A. Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice. The Journal of Nutritional Biochemistry. PMID 26344778 DOI: 10.1016/J.Jnutbio.2015.07.022  0.379
2015 Bag S, Tulsan R, Sood A, Cho H, Redjeb H, Zhou W, LeVine H, Török B, Török M. Sulfonamides as multifunctional agents for Alzheimer's disease. Bioorganic & Medicinal Chemistry Letters. 25: 626-30. PMID 25537270 DOI: 10.1016/J.Bmcl.2014.12.006  0.36
2015 Meier SE, Bell MC, Lyons D, Lee T, Chen J, Abner EL, Wilcock DM, LeVine H, Zhu H, Kayed R, Abisambra JF. P1-007: Association of pathological tau with the ribosomal complex impairs protein synthesis Alzheimer's & Dementia. 11: P338-P338. DOI: 10.1016/J.Jalz.2015.06.203  0.306
2014 Matveev SV, Kwiatkowski S, Sviripa VM, Fazio RC, Watt DS, LeVine H. Tritium-labeled (E,E)-2,5-bis(4'-hydroxy-3'-carboxystyryl)benzene as a probe for β-amyloid fibrils. Bioorganic & Medicinal Chemistry Letters. 24: 5534-6. PMID 25452000 DOI: 10.1016/J.Bmcl.2014.09.075  0.424
2014 Izzo NJ, Xu J, Zeng C, Kirk MJ, Mozzoni K, Silky C, Rehak C, Yurko R, Look G, Rishton G, Safferstein H, Cruchaga C, Goate A, Cahill MA, Arancio O, ... ... LeVine H, et al. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity. Plos One. 9: e111899. PMID 25390692 DOI: 10.1371/Journal.Pone.0111899  0.404
2014 Izzo NJ, Staniszewski A, To L, Fa M, Teich AF, Saeed F, Wostein H, Walko T, Vaswani A, Wardius M, Syed Z, Ravenscroft J, Mozzoni K, Silky C, Rehak C, ... ... LeVine H, et al. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. Plos One. 9: e111898. PMID 25390368 DOI: 10.1371/Journal.Pone.0111898  0.389
2014 Qosa H, LeVine H, Keller JN, Kaddoumi A. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model. Biochimica Et Biophysica Acta. 1842: 1806-15. PMID 24997450 DOI: 10.1016/J.Bbadis.2014.06.029  0.384
2014 Matveev SV, Spielmann HP, Metts BM, Chen J, Onono F, Zhu H, Scheff SW, Walker LC, LeVine H. A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain. Journal of Neurochemistry. 131: 356-68. PMID 24995708 DOI: 10.1111/Jnc.12815  0.415
2013 Bag S, Ghosh S, Tulsan R, Sood A, Zhou W, Schifone C, Foster M, LeVine H, Török B, Török M. Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease. Bioorganic & Medicinal Chemistry Letters. 23: 2614-8. PMID 23540646 DOI: 10.1016/J.Bmcl.2013.02.103  0.383
2013 Török B, Sood A, Bag S, Tulsan R, Ghosh S, Borkin D, Kennedy AR, Melanson M, Madden R, Zhou W, Levine H, Török M. Diaryl hydrazones as multifunctional inhibitors of amyloid self-assembly. Biochemistry. 52: 1137-48. PMID 23346953 DOI: 10.1021/Bi3012059  0.344
2012 Niedowicz DM, Beckett TL, Matveev S, Weidner AM, Baig I, Kryscio RJ, Mendiondo MS, LeVine H, Keller JN, Murphy MP. Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease. Annals of Neurology. 72: 564-70. PMID 23109151 DOI: 10.1002/Ana.23633  0.393
2012 Walker LC, LeVine H. Corruption and spread of pathogenic proteins in neurodegenerative diseases. The Journal of Biological Chemistry. 287: 33109-15. PMID 22879600 DOI: 10.1074/Jbc.R112.399378  0.342
2012 Török B, Sood A, Bag S, Kulkarni A, Borkin D, Lawler E, Dasgupta S, Landge S, Abid M, Zhou W, Foster M, LeVine H, Török M. Structure-activity relationships of organofluorine inhibitors of β-amyloid self-assembly. Chemmedchem. 7: 910-9. PMID 22351619 DOI: 10.1002/Cmdc.201100569  0.366
2012 LeVine H, Lampe L, Abdelmoti L, Augelli-Szafran CE. Dihydroxybenzoic acid isomers differentially dissociate soluble biotinyl-Aβ(1-42) oligomers. Biochemistry. 51: 307-15. PMID 22129351 DOI: 10.1021/Bi201288X  0.329
2012 Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ, LeVine H, Jucker M, Walker LC. Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. Journal of Neurochemistry. 120: 660-6. PMID 22017494 DOI: 10.1111/J.1471-4159.2011.07551.X  0.358
2011 Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H, Lovell MA, Murphy MP. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease. Plos One. 6: e24930. PMID 21949792 DOI: 10.1371/Journal.Pone.0024930  0.324
2011 Weidner AM, Housley M, Murphy MP, Levine H. Purified high molecular weight synthetic Aβ(1-42) and biological Aβ oligomers are equipotent in rapidly inducing MTT formazan exocytosis. Neuroscience Letters. 497: 1-5. PMID 21504780 DOI: 10.1016/J.Neulet.2011.03.082  0.323
2011 Rosen RF, Walker LC, Levine H. PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiology of Aging. 32: 223-34. PMID 19329226 DOI: 10.1016/J.Neurobiolaging.2009.02.011  0.353
2010 Ebenezer PJ, Weidner AM, LeVine H, Markesbery WR, Murphy MP, Zhang L, Dasuri K, Fernandez-Kim SO, Bruce-Keller AJ, Gavilán E, Keller JN. Neuron specific toxicity of oligomeric amyloid-β: role for JUN-kinase and oxidative stress. Journal of Alzheimer's Disease : Jad. 22: 839-48. PMID 20858948 DOI: 10.3233/Jad-2010-101161  0.327
2010 Murphy MP, Morales J, Beckett TL, Astarita G, Piomelli D, Weidner A, Studzinski CM, Dowling AL, Wang X, Levine H, Kryscio RJ, Lin Y, Barrett E, Head E. Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogs. Journal of Alzheimer's Disease : Jad. 22: 135-50. PMID 20847439 DOI: 10.3233/Jad-2010-100639  0.303
2010 Beckett TL, Niedowicz DM, Studzinski CM, Weidner AM, Webb RL, Holler CJ, Ahmed RR, LeVine H, Murphy MP. Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle. Neurobiology of Disease. 39: 449-56. PMID 20493261 DOI: 10.1016/J.Nbd.2010.05.018  0.364
2010 Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, Weidner AM, LeVine H, Keller JN, Markesbery WR. NOX activity is increased in mild cognitive impairment. Antioxidants & Redox Signaling. 12: 1371-82. PMID 19929442 DOI: 10.1089/Ars.2009.2823  0.338
2010 Rosen RF, Ciliax BJ, Wingo TS, Gearing M, Dooyema J, Lah JJ, Ghiso JA, LeVine H, Walker LC. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathologica. 119: 221-33. PMID 19690877 DOI: 10.1007/S00401-009-0583-3  0.406
2010 Levine H, Walker LC. Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiology of Aging. 31: 542-8. PMID 18619711 DOI: 10.1016/J.Neurobiolaging.2008.05.026  0.417
2009 Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, Patel ES, Baig I, Murphy MP, LeVine H, Kraner SD, Norris CM. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 12957-69. PMID 19828810 DOI: 10.1523/Jneurosci.1064-09.2009  0.373
2009 LeVine H, Ding Q, Walker JA, Voss RS, Augelli-Szafran CE. Clioquinol and other hydroxyquinoline derivatives inhibit Abeta(1-42) oligomer assembly. Neuroscience Letters. 465: 99-103. PMID 19664688 DOI: 10.1016/J.Neulet.2009.08.002  0.368
2009 Simons LJ, Caprathe BW, Callahan M, Graham JM, Kimura T, Lai Y, LeVine H, Lipinski W, Sakkab AT, Tasaki Y, Walker LC, Yasunaga T, Ye Y, Zhuang N, Augelli-Szafran CE. The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 654-7. PMID 19121939 DOI: 10.1016/J.Bmcl.2008.12.049  0.365
2008 Rosen RF, LeVine H, Walker LC. P2-067: PIB binding in Alzheimer's disease and nonhuman primate brain Alzheimer's & Dementia. 4: T387-T387. DOI: 10.1016/J.Jalz.2008.05.1140  0.397
2007 LeVine H. Small molecule inhibitors of Abeta assembly. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 185-97. PMID 17701466 DOI: 10.1080/13506120701461020  0.37
2007 Murphy MP, Beckett TL, Ding Q, Patel E, Markesbery WR, St Clair DK, LeVine H, Keller JN. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiology of Disease. 27: 301-11. PMID 17651976 DOI: 10.1016/J.Nbd.2007.06.002  0.377
2006 LeVine H. Biotin-avidin interaction-based screening assay for Alzheimer's beta-peptide oligomer inhibitors. Analytical Biochemistry. 356: 265-72. PMID 16729955 DOI: 10.1016/J.Ab.2006.04.036  0.377
2006 Walker L, LeVine H, Jucker M. Koch's postulates and infectious proteins Acta Neuropathologica. 112: 1-4. PMID 16703338 DOI: 10.1007/S00401-006-0072-X  0.326
2006 Rosen RF, LeVine H, Murphy M, Preuss TM, Ghiso JA, Farberg A, Gearing M, Walker LC. P2-005: Patterns of Aβ accumulation in Alzheimer's and aged primate brain Alzheimer's & Dementia. 2: S233-S233. DOI: 10.1016/J.Jalz.2006.05.842  0.335
2005 LeVine H. Multiple ligand binding sites on A beta(1-40) fibrils. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 12: 5-14. PMID 16076606 DOI: 10.1080/13506120500032295  0.362
2005 Walker LC, Ibegbu CC, Todd CW, Robinson HL, Jucker M, LeVine H, Gandy S. Emerging prospects for the disease-modifying treatment of Alzheimer's disease. Biochemical Pharmacology. 69: 1001-8. PMID 15763538 DOI: 10.1016/J.Bcp.2004.12.015  0.405
2005 Frackowiak J, Potempska A, LeVine H, Haske T, Dickson D, Mazur-Kolecka B. Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. Journal of Neuropathology and Experimental Neurology. 64: 82-90. PMID 15715088 DOI: 10.1093/Jnen/64.1.82  0.385
2004 LeVine H. Alzheimer's beta-peptide oligomer formation at physiologic concentrations. Analytical Biochemistry. 335: 81-90. PMID 15519574 DOI: 10.1016/J.Ab.2004.08.014  0.358
2004 Sweeney D, Martins R, LeVine H, Smith JD, Gandy S. Similar promotion of Abeta1-42 fibrillogenesis by native apolipoprotein E epsilon3 and epsilon4 isoforms. Journal of Neuroinflammation. 1: 15. PMID 15312232 DOI: 10.1186/1742-2094-1-15  0.316
2004 LeVine H. The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide. Journal of Alzheimer's Disease : Jad. 6: 303-14. PMID 15201485 DOI: 10.3233/Jad-2004-6311  0.387
2004 LeVine H. P1-223 Alzheimer's β-peptide oligomer formation at physiologic concentrations Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80536-0  0.331
2003 LeVine H. Y10W beta(1-40) fluorescence reflects epitope exposure in conformers of Alzheimer's beta-peptide. Archives of Biochemistry and Biophysics. 417: 112-22. PMID 12921787 DOI: 10.1016/S0003-9861(03)00322-9  0.312
2002 Walker LC, Bian F, Callahan MJ, Lipinski WJ, Durham RA, LeVine H. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids. 23: 87-93. PMID 12373522 DOI: 10.1007/S00726-001-0113-7  0.4
2002 LeVine H. 4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40). Archives of Biochemistry and Biophysics. 404: 106-15. PMID 12127075 DOI: 10.1016/S0003-9861(02)00246-1  0.308
2002 LeVine H. The challenge of inhibiting Abeta polymerization. Current Medicinal Chemistry. 9: 1121-33. PMID 12052176 DOI: 10.2174/0929867023370167  0.347
2001 Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, Lipinski WJ, Walker LC, LeVine H. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiology of Aging. 22: 49-61. PMID 11164276 DOI: 10.1016/S0197-4580(00)00181-0  0.352
2000 Walker LC, LeVine H. The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly. Molecular Neurobiology. 21: 83-95. PMID 11327151 DOI: 10.1385/Mn:21:1-2:083  0.354
2000 Walker LC, LeVine H. The cerebral proteopathies. Neurobiology of Aging. 21: 559-61. PMID 10924770 DOI: 10.1016/S0197-4580(00)00160-3  0.341
2000 LeVine H. 125I-labeled ApoE binds competitively to β(1-40) fibrils with pathological chaperone proteins Amyloid. 7: 83-89. PMID 10842709 DOI: 10.3109/13506120009146243  0.394
2000 Watson MD, Evans LM, Haske T, Spiegel K, Raby CA, Brown KL, LeVine H, Emmerling MR. Detection of oligomeric β-amyloid peptide in biological samples using a singlesite monoclonal antibody sandwich enzyme-linked immunoabsorbant assay Neurobiology of Aging. 21: 90. DOI: 10.1016/S0197-4580(00)82630-5  0.307
1999 LeVine H, Scholten JD. Screening for pharmacologic inhibitors of amyloid fibril formation. Methods in Enzymology. 309: 467-476. PMID 10507041 DOI: 10.1016/S0076-6879(99)09031-X  0.4
1999 LeVine H. Quantification Of Beta -Sheet Amyloid Fibril Structures With Thioflavin T Methods in Enzymology. 309: 274-284. PMID 10507030 DOI: 10.1016/S0076-6879(99)09020-5  0.392
1999 Augelli-Szafran CE, Walker LC, LeVine H. Chapter 3. β-Amyloid as a Target for Alzheimer's Disease Therapy Annual Reports in Medicinal Chemistry. 34: 21-30. DOI: 10.1016/S0065-7743(08)60565-5  0.401
1997 Levine H. Stopped-Flow Kinetics Reveal Multiple Phases of Thioflavin T Binding to Alzheimer β(1-40) Amyloid Fibrils Archives of Biochemistry and Biophysics. 342: 306-316. PMID 9186492 DOI: 10.1006/Abbi.1997.0137  0.383
1996 Haske TN, DeBlasi A, LeVine H. An Intact N Terminus of the Subunit Is Required for the G Stimulation of Rhodopsin Phosphorylation by Human -Adrenergic Receptor Kinase-1 but Not for Kinase Binding Journal of Biological Chemistry. 271: 2941-2948. PMID 8621684 DOI: 10.1074/Jbc.271.6.2941  0.312
1995 Levine H. Soluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solution Neurobiology of Aging. 16: 755-764. PMID 8532108 DOI: 10.1016/0197-4580(95)00052-G  0.354
1995 Pumiglia KM, LeVine H, Haske T, Habib T, Jove R, Decker SJ. A direct interaction between G-protein βγ subunits and the Raf-1 protein kinase Journal of Biological Chemistry. 270: 14251-14254. PMID 7782277 DOI: 10.1074/Jbc.270.24.14251  0.31
1995 Chuang TT, Levine H, Blasi AD. Phosphorylation and activation of beta-adrenergic receptor kinase by protein kinase C. Journal of Biological Chemistry. 270: 18660-18665. PMID 7629197 DOI: 10.1074/Jbc.270.31.18660  0.308
1995 LeVine H. Thioflavine T interaction with amyloid β-sheet structures Amyloid. 2: 1-6. DOI: 10.3109/13506129509031881  0.389
1993 Levine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Science. 2: 404-410. PMID 8453378 DOI: 10.1002/Pro.5560020312  0.348
1992 Nichols JS, LeVine H, Smith GF, Wypij DM, Wiseman JS. Determination of endothelin by an immobilized receptor assay utilizing a 96-well format. Journal of Biochemical and Biophysical Methods. 25: 173-84. PMID 1491102 DOI: 10.1016/0165-022X(92)90009-Y  0.306
1990 LeVine H, Smith DP, Whitney M, Malicki DM, Dolph PJ, Smith GF, Burkhart W, Zuker CS. Isolation of a novel visual-system-specific arrestin: an in vivo substrate for light-dependent phosphorylation. Mechanisms of Development. 33: 19-25. PMID 2129011 DOI: 10.1016/0925-4773(90)90131-5  0.302
1988 LeVine H, Sahyoun NE. Two types of brain calmodulin-dependent protein kinase II: morphological, biochemical and immunochemical properties. Brain Research. 439: 47-55. PMID 2833988 DOI: 10.1016/0006-8993(88)91460-6  0.325
1987 Levine H, Sahyoun NE. Characterization of a soluble Mr‐30000 catalytic fragment of the neuronal calmodulin‐dependent protein kinase II Febs Journal. 168: 481-486. PMID 3311750 DOI: 10.1111/J.1432-1033.1987.Tb13442.X  0.311
1986 Burgess SK, Sahyoun N, Blanchard SG, LeVine H, Chang KJ, Cuatrecasas P. Phorbol ester receptors and protein kinase C in primary neuronal cultures: development and stimulation of endogenous phosphorylation. The Journal of Cell Biology. 102: 312-9. PMID 3941157 DOI: 10.1083/Jcb.102.1.312  0.315
1986 LeVine H, Sahyoun NE. Involvement of fodrin-binding proteins in the structure of the neuronal postsynaptic density and regulation by phosphorylation. Biochemical and Biophysical Research Communications. 138: 59-65. PMID 2943277 DOI: 10.1016/0006-291X(86)90246-9  0.323
1985 LeVine H, Sahyoun NE, Cuatrecasas P. Calmodulin binding to the cytoskeletal neuronal calmodulin-dependent protein kinase is regulated by autophosphorylation. Proceedings of the National Academy of Sciences of the United States of America. 82: 287-91. PMID 3855553 DOI: 10.1073/Pnas.82.2.287  0.304
1984 Wolf M, Sahyoun N, LeVine H, Cuatrecasas P. Protein kinase C: rapid enzyme purification and substrate-dependence of the diacylglycerol effect. Biochemical and Biophysical Research Communications. 122: 1268-75. PMID 6236807 DOI: 10.1016/0006-291X(84)91229-4  0.303
1983 Sahyoun N, LeVine H, McConnell R, Bronson D, Cuatrecasas P. A specific phosphoprotein phosphatase acts on histone H1 phosphorylated by protein kinase C. Proceedings of the National Academy of Sciences of the United States of America. 80: 6760-4. PMID 6316323 DOI: 10.1073/Pnas.80.22.6760  0.303
1981 Sahyoun NE, LeVine H, Davis J, Hebdon GM, Cuatrecasas P. Molecular complexes involved in the regulation of adenylate cyclase. Proceedings of the National Academy of Sciences of the United States of America. 78: 6158-62. PMID 6273855 DOI: 10.1073/Pnas.78.10.6158  0.315
Show low-probability matches.